United Therapeutics (UTHR) grants director Victor Dzau RSUs and stock options
Rhea-AI Filing Summary
United Therapeutics Corporation director Victor J. Dzau reported equity awards received on July 22, 2026 in connection with his appointment to the Board. He was granted 730 restricted stock units and 2,300 stock options under the Non-Employee Director Compensation Program. Each RSU represents one share of common stock upon vesting. The stock options cover common stock at an exercise price of $527.0700 per share, vest on the one-year anniversary of the grant date, and expire on July 22, 2033.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
DZAU VICTOR J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit F1, F2, F3 | 730 | $0.00 | $0.00 |
| Grant/Award | Stock Option F2 | 2,300 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 730 shares (Direct);
Stock Option — 2,300 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F2. In connection with Dr. Dzau's appointment to the Board of Directors on July 22, 2026, he was awarded restricted stock units and stock options in accordance with the Non-Employee Director Compensation Program, as follows: (a) 380 restricted stock units and 1,190 stock options, representing his initial grant upon joining the Board, and (b) 350 restricted stock units and 1,110 stock options, which are pro-rata grants representing the remainder of the 2026-2027 Board service year. Each award becomes fully vests on the one-year anniversary of the grant date.
- F3. Not applicable as restricted stock units do not have an expiration date.
Key Figures
Restricted Stock Units Granted: 730 units
Stock Options Granted: 2,300 options
Stock Option Exercise Price: $527.0700 per share
+2 more
5 metrics
Restricted Stock Units Granted
730 units
Equity awards to Victor J. Dzau on July 22, 2026
Stock Options Granted
2,300 options
Equity awards to Victor J. Dzau on July 22, 2026
Stock Option Exercise Price
$527.0700 per share
Exercise price for 2,300 stock options granted July 22, 2026
Vesting Timing
One-year anniversary of grant date
Each award becomes fully vested one year after July 22, 2026
Option Expiration Date
July 22, 2033
Expiration of stock options granted to Victor J. Dzau
Key Terms
Restricted Stock Unit, Stock Option, Non-Employee Director Compensation Program, exercise price, +1 more
5 terms
Restricted Stock Unit financial
"Each restricted stock unit represents the right to receive, following vesting, one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option financial
"he was awarded restricted stock units and stock options in accordance with the program"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Non-Employee Director Compensation Program financial
"awarded restricted stock units and stock options in accordance with the Non-Employee Director Compensation Program"
exercise price financial
"Stock Option transaction shows an exercise price of 527.0700 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"Each award becomes fully vests on the one-year anniversary of the grant date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did United Therapeutics (UTHR) report for Victor J. Dzau?
United Therapeutics reported that director Victor J. Dzau received equity awards on July 22, 2026. He was granted 730 restricted stock units and 2,300 stock options in connection with his appointment to the Board under the Non-Employee Director Compensation Program.
How many restricted stock units did Victor J. Dzau receive from UTHR?
Victor J. Dzau received 730 restricted stock units from United Therapeutics. Each restricted stock unit represents the right to receive one share of United Therapeutics common stock after the units vest on the one-year anniversary of the July 22, 2026 grant date.
What stock options were granted to Victor J. Dzau by United Therapeutics (UTHR)?
Victor J. Dzau was granted 2,300 stock options for United Therapeutics common stock. The options have an exercise price of $527.0700 per share, vest on the one-year anniversary of the July 22, 2026 grant date, and expire on July 22, 2033.
How are Victor J. Dzau’s UTHR equity awards structured between initial and pro-rata grants?
Victor J. Dzau’s awards include an initial grant of 380 RSUs and 1,190 options, plus pro-rata grants of 350 RSUs and 1,110 options. These pro-rata grants represent the remainder of the 2026–2027 Board service year under the Non-Employee Director Compensation Program.
When do Victor J. Dzau’s United Therapeutics (UTHR) director awards vest and expire?
Both the restricted stock units and stock options awarded to Victor J. Dzau fully vest one year after the July 22, 2026 grant date. The stock options then remain exercisable until their stated expiration on July 22, 2033; the RSUs do not have an expiration date.
Were Victor J. Dzau’s UTHR equity grants made under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not affirmatively marked for these transactions. The awards are described as grants made under the Non-Employee Director Compensation Program in connection with his appointment to the United Therapeutics Board.